Caricamento...
Narrative review: the holy grail: update on pharmacotherapy for heart failure with preserved ejection fraction
Heart failure with preserved ejection fraction (HFpEF) is the presence of clinical signs and/or symptoms of heart failure with a left ventricular ejection fraction (LVEF) ≥50%. Risk factors associated with this disease include hypertension, hyperlipidemia, atrial fibrillation (AF), obesity, diabetes...
Salvato in:
| Pubblicato in: | Ann Transl Med |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AME Publishing Company
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8039660/ https://ncbi.nlm.nih.gov/pubmed/33850920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-4602 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|